TY - T1的回答:大剂量糖皮质激素beneficial in COVID-19? JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00324-2021 VL - 57 IS - 4 SP - 2100324 AU - Edalatifard, Maryam AU - Akhtari, Maryam AU - Salehi, Mohammadreza AU - Farhadi, Elham AU - Jamshidi, Ahmadreza AU - Mahmoudi, Mahdi AU - Rostamian, Abdolrahman Y1 - 2021/04/01 UR - //www.qdcxjkg.com/content/57/4/2100324.abstract N2 - In their correspondence, V. Muthu and co-workers raise some issues related to our recent clinical trial “Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial” [1]. This provides a welcome opportunity to further explain the outcome of using a high dose of glucocorticoid for the treatment of patients with severe coronavirus disease 2019 (COVID-19).Our clinical trial supports the beneficial use of a high dose of methylprednisolone for the treatment of severe COVID-19 patients. https://bit.ly/3qvc4Kz ER -